Prof. Dr. Matthias Heringlake – Peer-to-peer review: Levosimendan as a first-line inotrope in cardiac surgery – Practical aspect, limitations and pitfalls

Discover the triple effects of levosimendan and take a look at the literature supporting its use as a first-line therapy. This drug has different pharmacokinetics from other inotropes, in particular its ability to increase glomerular filtrate rate. Learn more about the rationale for levosimendan use in the pre-,  peri- and post-operative period in different patient types and scenarios as Prof. Dr Matthias gives an overview of relevant supporting clinical data.

View other expert videos and find out more about the role and potential benefits of levosimendan


ISICEM 2019 resources

Videos (5)
Login/ Register Maximise Minimise